PCL-5 — PTSD Checklist for DSM-5
The PCL-5 is a 20-item self-report measure assessing the presence and severity of PTSD symptoms based on DSM-5 criteria. It covers intrusion, avoidance, negative alterations in cognition and mood, and alterations in arousal and reactivity.
About
The PTSD Checklist for DSM-5 (PCL-5) is a 20-item self-report measure developed by the National Center for PTSD to assess PTSD symptoms per DSM-5 criteria. Each item is rated on a 5-point Likert scale from 0 (Not at all) to 4 (Extremely), yielding a total severity score ranging from 0 to 80. The PCL-5 consists of four symptom clusters: intrusion (items 1-5), avoidance (items 6-7), negative alterations in cognition and mood (items 8-14), and alterations in arousal and reactivity (items 15-20). A cutoff score of 32-33 is commonly used to indicate a provisional PTSD diagnosis. The PCL-5 has demonstrated excellent psychometric properties with internal consistency (α = 0.94-0.96), test-retest reliability (r = 0.82-0.96), and convergent/discriminant validity. It can be administered in 5-10 minutes and is widely used in clinical, research, and primary care settings.
Formula
PCL-5 Score = q1 + q2 + q3 + ... + q20 (each item 0-4, total 0-80)
The PCL-5 score is the simple sum of all 20 item responses. Each item is rated from 0 (Not at all) to 4 (Extremely). The total score ranges from 0 to 80. Higher scores indicate greater PTSD symptom severity. The four symptom clusters correspond to DSM-5 diagnostic criteria B through E: intrusion (items 1-5), avoidance (items 6-7), negative cognition/mood (items 8-14), and arousal/reactivity (items 15-20).
Score Interpretation
The PCL-5 is the gold standard self-report measure for PTSD symptom assessment in both clinical and research settings. It aligns directly with DSM-5 diagnostic criteria and provides both a total severity score and cluster-specific scores for intrusion, avoidance, negative cognition/mood, and arousal/reactivity. The established cutoff of 32-33 provides excellent diagnostic efficiency with sensitivity of 0.78-0.94 and specificity of 0.82-0.92 depending on the population. The PCL-5 is sensitive to change over time, making it useful for monitoring treatment response. It has been validated across diverse populations including military veterans, civilian trauma survivors, primary care patients, and college students. The PCL-5 is recommended by the National Center for PTSD, the VA/DoD Clinical Practice Guideline, and the ISTSS Treatment Guidelines.
Low (below clinical cutoff) — 0–31
Score below 32. No provisional PTSD diagnosis.
Management: Routine monitoring; no further PTSD-specific assessment needed at this time.
Moderate (meets provisional diagnosis threshold) — 32–38
Score of 32-38. Meets provisional PTSD diagnosis threshold.
Management: Conduct structured clinical interview (CAPS-5) for definitive diagnosis. Monitor symptoms.
High (clinically significant) — 39–80
Score of 39 or higher. Clinically significant PTSD symptoms.
Management: Refer to mental health specialist for evidence-based PTSD treatment (trauma-focused CBT, EMDR, pharmacotherapy).
Reference Ranges
| Population | Normal Range | Notes |
|---|---|---|
| Adults (18+ years) | 0 – 31 (Below cutoff) | No provisional PTSD diagnosis indicated |
| Adults (18+ years) | 32 – 38 (Threshold) | Meets provisional diagnosis; further assessment needed |
| Adults (18+ years) | 39 – 80 (High) | Clinically significant; treatment recommended |
Dr. Ahmed Abdelrahman
Dr. Ahmed is a healthcare management consultant with over 15 years of experience in clinical practice and medical education.
View medical review board & editorial policy →Example Calculation
A 35-year-old female presents with difficulty sleeping and hypervigilance after a motor vehicle accident 3 months ago. On PCL-5 assessment: she reports moderate to severe symptoms across all clusters. Item scores include intrusive memories (3), distressing dreams (4), avoidance of driving (4), negative beliefs (3), hypervigilance (4), and startle (3). Total PCL-5 score = 58/80. This exceeds the clinical cutoff of 32, indicating clinically significant PTSD symptoms. Clinical recommendation: refer to trauma-focused CBT and consider CAPS-5 structured interview for definitive diagnosis.
Related Conditions
Related Medications
Common Mistakes
Using PCL-5 as a standalone diagnostic tool without clinical interview
PCL-5 is a screening tool, not a diagnostic instrument. A positive screen requires confirmation with a structured clinical interview such as CAPS-5.
Using inconsistent cutoff scores across different populations
The standard cutoff is 32-33, but lower cutoffs (28-30) may be appropriate for primary care or screening populations to maximize sensitivity.
Not assessing for negative response bias when scores are very high
Very high scores (70+) may indicate response bias or extreme distress. Consider using validity scales or clinical judgment to interpret results.
Frequently Asked Questions
What is the PCL-5 cutoff score for PTSD diagnosis?
How long does the PCL-5 take to complete?
Can the PCL-5 be used to monitor treatment progress?
Is the PCL-5 available for free?
References
- Weathers FW, Litz BT, Keane TM, Palmieri PA, Marx BP, Schnurr PP. The PTSD Checklist for DSM-5 (PCL-5). National Center for PTSD; 2013.
- Blevins CA, Weathers FW, Davis MT, Witte TK, Domino JL. The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): development and initial psychometric evaluation. J Trauma Stress. 2015;28(6):489-498. PubMed
- Bovin MJ, Marx BP, Weathers FW, et al. Psychometric properties of the PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (PCL-5) in veterans. Psychol Assess. 2016;28(11):1379-1391. PubMed